Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Psychiatry Res

Retrieve available abstracts of 292 articles:
HTML format

Single Articles

    July 2022
  1. RIBOLSI M, Albergo G, Fiori Nastro F, Pelle M, et al
    Autistic symptomatology in UHR patients: A preliminary report.
    Psychiatry Res. 2022;313:114634.
    PubMed     Abstract available

  2. NGUYEN T, Frayne J, Watson S, Lebedevs T, et al
    Long-acting injectable antipsychotic treatment during pregnancy: Outcomes for women at a tertiary maternity hospital.
    Psychiatry Res. 2022;313:114614.
    PubMed     Abstract available

    May 2022
  3. LI Z, Li X, Jin M, Liu Y, et al
    Identification of potential biomarkers and their correlation with immune infiltration cells in schizophrenia using combinative bioinformatics strategy.
    Psychiatry Res. 2022;314:114658.
    PubMed     Abstract available

  4. SHIMADA T, Ito S, Makabe A, Yamanushi A, et al
    Aerobic exercise and cognitive functioning in schizophrenia: An updated systematic review and meta-analysis.
    Psychiatry Res. 2022;314:114656.
    PubMed     Abstract available

  5. KIRSCHENBAUM MA, Lopez LV, de Filippis R, Ali AF, et al
    Validation of a novel Psychosis-Implicit Association Test (P-IAT) as a diagnostic support tool.
    Psychiatry Res. 2022;314:114647.
    PubMed     Abstract available

  6. BHATTACHARYYA U, Bhatia T, Deshpande SN, Thelma BK, et al
    Genetic variations in evolutionary accelerated regions disrupt cognition in schizophrenia.
    Psychiatry Res. 2022;314:114586.
    PubMed     Abstract available

  7. XU L, Hao D, Wei Y, Cui H, et al
    Effect of cognitive insight on clinical insight from pre-morbid to early psychosis stages.
    Psychiatry Res. 2022;313:114613.
    PubMed     Abstract available

  8. CAO X, Chen S, Xu H, Wang Q, et al
    Global functioning, cognitive function, psychopathological symptoms in untreated patients with first-episode schizophrenia: A cross-sectional study.
    Psychiatry Res. 2022;313:114616.
    PubMed     Abstract available

  9. LONG J, Tian L, Baranova A, Cao H, et al
    Convergent lines of evidence supporting involvement of NFKB1 in schizophrenia.
    Psychiatry Res. 2022;312:114588.
    PubMed     Abstract available

  10. KATZ IR, Szymanski BR, Marder SR, Shotwell A, et al
    Comparative risks of all-cause mortality for Veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications.
    Psychiatry Res. 2022;313:114590.
    PubMed     Abstract available

    April 2022
  11. THAI H, Robertson C, Friberg L, Hatko A, et al
    WHODAS 2.0: Associations of functional disability with sex, age, and length of care in outpatients with schizophrenia-spectrum disorders.
    Psychiatry Res. 2022;313:114583.
    PubMed     Abstract available

  12. MARTINS PS, Caldas F, Oliveira C, Mota J, et al
    A 10-year mirror-image study of effectiveness and cost of long-acting paliperidone palmitate injectable in patients with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2022;312:114581.
    PubMed     Abstract available

  13. LI X, Yuan X, Pang L, Zhang S, et al
    nThe effect of serum lipids and short-chain fatty acids on cognitive functioning in drug-naive, first episode schizophrenia patients.
    Psychiatry Res. 2022;313:114582.
    PubMed     Abstract available

  14. XU Y, Cai Z, Fang C, Zheng J, et al
    Impact of aerobic exercise on cognitive function in patients with schizophrenia during daily care: A meta-analysis.
    Psychiatry Res. 2022;312:114560.
    PubMed     Abstract available

  15. OUYANG H, Huang M, Chen S, Wu X, et al
    Peripheral lower triiodothyronine levels related to interleukin-6 in patients with first-episode schizophrenia.
    Psychiatry Res. 2022;312:114546.

  16. WELCH KG, Stiles BJ, Palsson OS, Meyer-Kalos PS, et al
    The use of diary methods to evaluate daily experiences in first-episode psychosis.
    Psychiatry Res. 2022;312:114548.
    PubMed     Abstract available

  17. GONZALEZ-RODRIGUEZ A, Monreal JA, Porras-Segovia A, Cervilla JA, et al
    Psychometric instruments for the assessment of depressive symptoms in patients with delusional disorder: A systematic review.
    Psychiatry Res. 2022;310:114435.
    PubMed     Abstract available

    March 2022
  18. JAISWAL N, Kar SK, Gupta PK
    Comments on "High frequency repetitive transcranial magnetic stimulation of dorsomedial prefrontal cortex for negative symptoms in patients with schizophrenia: A double-blind, randomized controlled trial".
    Psychiatry Res. 2022;312:114532.

  19. PANDOLFO G, Genovese G, Bruno A, Campolo D, et al
    Advanced glycation end-products and advanced oxidation protein products in schizophrenia.
    Psychiatry Res. 2022;311:114527.
    PubMed     Abstract available

  20. LI J, Zhang X, Jiang J, Zhang B, et al
    Comparison of electroconvulsive therapy and magnetic seizure therapy in schizophrenia: Structural changes/neuroplasticity.
    Psychiatry Res. 2022;312:114523.
    PubMed     Abstract available

  21. BORNHEIMER LA, Li Verdugo J, Holzworth J, Im V, et al
    Modifying a cognitive behavioral suicide prevention treatment for adults with schizophrenia spectrum disorders in community mental health.
    Psychiatry Res. 2022;311:114505.
    PubMed     Abstract available

  22. XU X, Shao G, Zhang X, Hu Y, et al
    The efficacy of nutritional supplements for the adjunctive treatment of schizophrenia in adults: A systematic review and network meta-analysis.
    Psychiatry Res. 2022;311:114500.
    PubMed     Abstract available

  23. RAMMOUZ I, Bouri S, Merzouki M, Berraho MA, et al
    Reliability of self-report of cannabis use among patients with schizophrenia.
    Psychiatry Res. 2022;311:114491.

  24. KEMPPAINEN A, Lindgren M, Suvisaari J, Kieseppa T, et al
    Adverse childhood experiences and social and occupational functioning in first-episode psychosis - A one year follow - up.
    Psychiatry Res. 2022;311:114502.

  25. MUNIR K, Oner O, Kerala C, Rustamov I, et al
    Social distance and stigma towards persons with serious mental illness among medical students in five European Central Asia countries.
    Psychiatry Res. 2022;309:114409.
    PubMed     Abstract available

    February 2022
  26. GOHARI E, Moore RC, Depp CA, Ackerman RA, et al
    Momentary severity of psychotic symptoms predicts overestimation of competence in domains of everyday activities and work in schizophrenia: An ecological momentary assessment study.
    Psychiatry Res. 2022;310:114487.
    PubMed     Abstract available

  27. LIU Y, Jia LN, Wu H, Jiang W, et al
    Adjuvant electroconvulsive therapy with antipsychotics is associated with improvement in auditory mismatch negativity in schizophrenia.
    Psychiatry Res. 2022;311:114484.

  28. COWAN T, Cohen AS, Raugh IM, Strauss GP, et al
    Ambulatory audio and video recording for digital phenotyping in schizophrenia: Adherence & data usability.
    Psychiatry Res. 2022;311:114485.
    PubMed     Abstract available

  29. SANTESTEBAN-ECHARRI O, Sandel D, Liu L, Bearden CE, et al
    Family history of psychosis in youth at clinical high risk: A replication study.
    Psychiatry Res. 2022;311:114480.
    PubMed     Abstract available

  30. MORIKAWA R, Watanabe Y, Igeta H, Arta RK, et al
    Novel missense SETD1A variants in Japanese patients with schizophrenia: Resequencing and association analysis.
    Psychiatry Res. 2022;310:114481.
    PubMed     Abstract available

  31. RODRIGUEZ M, Knizkova K, Kerkova B, Sironova A, et al
    The relationships between cognitive reserve, cognitive functioning and quality of life in first-episode schizophrenia spectrum disorders.
    Psychiatry Res. 2022;310:114479.
    PubMed     Abstract available

  32. LEE HS, Rast C, Shenoy S, Dean D, et al
    A meta-analytic review of transcranial direct current stimulation (tDCS) on general psychopathology symptoms of schizophrenia; immediate improvement followed by a return to baseline.
    Psychiatry Res. 2022;310:114471.
    PubMed     Abstract available

  33. SONG W, Lin GN, Yu S, Zhao M, et al
    Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality.
    Psychiatry Res. 2022;310:114453.
    PubMed     Abstract available

  34. TAN EJ, Toh WL, Rossell SL
    Examining relationships between state and trait psychotic symptoms and quality of life in schizophrenia spectrum disorders.
    Psychiatry Res. 2022;310:114450.
    PubMed     Abstract available

  35. LOPEZ-NAVARRO E, Fonseca-Pedrero E, Errasti J, Al-Halabi S, et al
    Mindfulness improves theory of mind in people experiencing psychosis: A pilot randomized clinical trial.
    Psychiatry Res. 2022;310:114440.
    PubMed     Abstract available

  36. GOH XX, Tang PY, Tee SF
    Effects of antipsychotics on antioxidant defence system in patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2022;309:114429.
    PubMed     Abstract available

  37. SCHWARTZ EK, Le TP, Cohen AS
    Sharing positive events: Ecological momentary assessment of emotion regulation via social capitalization in schizotypy.
    Psychiatry Res. 2022;308:114377.
    PubMed     Abstract available

  38. GROENMAN AP, van der Werf S, Geurts HM
    Subjective cognition in adults with common psychiatric classifications; a systematic review.
    Psychiatry Res. 2022;308:114374.
    PubMed     Abstract available

    January 2022
  39. JEONG JH, Kim SW, Lee BJ, Kim JJ, et al
    The factor structure and clinical utility of clinician-rated dimensions of psychosis symptom severity in patients with recent-onset psychosis: Results of a 1-year longitudinal follow-up prospective cohort study.
    Psychiatry Res. 2022;310:114420.
    PubMed     Abstract available

  40. BARTOLI F, Cavaleri D, Callovini T, Riboldi I, et al
    Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study.
    Psychiatry Res. 2022;309:114405.
    PubMed     Abstract available

  41. LUNDIN NB, Jones MN, Myers EJ, Breier A, et al
    Semantic and phonetic similarity of verbal fluency responses in early-stage psychosis.
    Psychiatry Res. 2022;309:114404.
    PubMed     Abstract available

  42. XIE Y, He Y, Guan M, Wang Z, et al
    Low-frequency rTMS treatment alters the topographical organization of functional brain networks in schizophrenia patients with auditory verbal hallucination.
    Psychiatry Res. 2022;309:114393.
    PubMed     Abstract available

  43. RAULT O, Lamothe H, Pelissolo A
    Therapeutic use of virtual reality relaxation in schizophrenia: A pilot study.
    Psychiatry Res. 2022;309:114389.
    PubMed     Abstract available

  44. VERDOUX H, Sibert A, Quiles C
    Trauma and resistance to antipsychotic treatment in schizophrenia: A narrative review.
    Psychiatry Res. 2022;309:114392.
    PubMed     Abstract available

  45. MORAN LV, Tsang ES, Ongur D, Hsu J, et al
    Geographical variation in hospitalization for psychosis associated with cannabis use and cannabis legalization in the United States: Submit to: Psychiatry Research.
    Psychiatry Res. 2022;308:114387.
    PubMed     Abstract available

  46. SINGH A, Kumar V, Pathak H, Jacob AA, et al
    Effect of antipsychotic dose reduction on cognitive function in schizophrenia.
    Psychiatry Res. 2022;308:114383.
    PubMed     Abstract available

  47. GANDHI A, Mote J, Fulford D
    A transdiagnostic meta-analysis of physical and social Anhedonia in major depressive disorder and schizophrenia spectrum disorders.
    Psychiatry Res. 2022;309:114379.
    PubMed     Abstract available

    December 2021
  48. LABONTE C, Zhand N, Park A, Harvey PD, et al
    Complete blood count inflammatory markers in treatment-resistant schizophrenia: Evidence of association between treatment responsiveness and levels of inflammation.
    Psychiatry Res. 2021;308:114382.
    PubMed     Abstract available

  49. GICAS KM, Parmar PK, Fabiano GF, Mashhadi F, et al
    Substance-induced psychosis and cognitive functioning: A systematic review.
    Psychiatry Res. 2021;308:114361.
    PubMed     Abstract available

  50. GARRIDO-TORRES N, Suarez-Suarez ML, Rocha-Gonzalez I, Alameda L, et al
    Higher rates of first episode psychosis in immigrants admitted in inpatient unit at southwest Spain.
    Psychiatry Res. 2021;308:114352.
    PubMed     Abstract available

  51. VERU F, MacDonald K, Malla A, Pruessner M, et al
    The effects of childhood adversity on treatment delays and its components in first-episode psychosis.
    Psychiatry Res. 2021;308:114341.
    PubMed     Abstract available

  52. LAVAUD P, McMahon K, Sanchez Rico M, Hanon C, et al
    Long-term care utilization within older adults with schizophrenia: Associated factors in a multicenter study.
    Psychiatry Res. 2021;308:114339.
    PubMed     Abstract available

  53. LIU X, Wang D, Fan R, Wang R, et al
    Life expectancy and potential years of life lost for schizophrenia in western China.
    Psychiatry Res. 2021;308:114330.
    PubMed     Abstract available

  54. LOCKWOOD L, Miller B, Youssef NA
    Epigenetics and first-episode psychosis: A systematic review.
    Psychiatry Res. 2021;307:114325.
    PubMed     Abstract available

  55. THOMPSON EC, Visser KF, Schiffman J, Spirito A, et al
    Preliminary evidence supporting the practice of psychosis-risk screening within an inpatient psychiatric setting serving adolescents.
    Psychiatry Res. 2021;307:114322.
    PubMed     Abstract available

  56. LEE S, Schwartz S
    Adherence and persistence to long-acting injectable dopamine receptor blocking agent therapy in the United States: A systematic review and meta-analysis of cohort studies.
    Psychiatry Res. 2021;306:114277.
    PubMed     Abstract available

    November 2021
  57. LOCH AA, Mota NB, Rossler W, Gattaz WF, et al
    Exacerbation of psychosis risk during the COVID-19 pandemic: The disproportionate impact on the lower income population.
    Psychiatry Res. 2021;307:114319.

  58. ALLIENDE LM, Czepielewski LS, Aceituno D, Castaneda CP, et al
    Gender, age and geographical representation over the past 50 years of schizophrenia research.
    Psychiatry Res. 2021;307:114279.
    PubMed     Abstract available

  59. FERNANDEZ DK, Deane FP, Vella SA
    Effects of online continuum and categorical belief manipulations on schizophrenia stigma, help-seeking, and help-provision.
    Psychiatry Res. 2021;307:114293.
    PubMed     Abstract available

  60. CHEN S, Tang Y, Fan X, Qiao Y, et al
    The role of white matter abnormality in the left anterior corona radiata: In relation to formal thought disorder in patients with schizophrenia.
    Psychiatry Res. 2021;307:114302.
    PubMed     Abstract available

  61. GOU N, Xiang Y, Zhou J, Zhang S, et al
    Identification of violent patients with schizophrenia using a hybrid machine learning approach at the individual level.
    Psychiatry Res. 2021;306:114294.
    PubMed     Abstract available

  62. LAI M, Hegde R, Kelly S, Bannai D, et al
    Investigating sleep spindle density and schizophrenia: A meta-analysis.
    Psychiatry Res. 2021;307:114265.
    PubMed     Abstract available

  63. BARR SM, Roberts D, Thakkar KN
    Psychosis in transgender and gender non-conforming individuals: A review of the literature and a call for more research.
    Psychiatry Res. 2021;306:114272.
    PubMed     Abstract available

  64. LYU J, Zhang J
    Suicide means, timing, intent and behavior characteristics of the suicides with schizophrenia.
    Psychiatry Res. 2021;306:114267.
    PubMed     Abstract available

  65. RUSSO M, Consoli S, De Rosa MA, Calisi D, et al
    A case of Sars-Cov-2-related mania with prominent psychosis>.
    Psychiatry Res. 2021;306:114266.

  66. GALLOS IK, Mantonakis L, Spilioti E, Kattoulas E, et al
    The relation of integrated psychological therapy to resting state functional brain connectivity networks in patients with schizophrenia.
    Psychiatry Res. 2021;306:114270.
    PubMed     Abstract available

  67. SANTOS MJ, Ferreira TF, Sequeira M, Trancas B, et al
    Chronic hallucinatory psychosis presenting with olfactory hallucinations: A case report.
    Psychiatry Res. 2021;305:114262.

  68. SAHYOUNI C, Hefazi E
    Clozapine induced pericarditis: A case report.
    Psychiatry Res. 2021;305:114250.
    PubMed     Abstract available

  69. SHROITMAN NK, Peles E, Even-Tov S, Schreiber S, et al
    False-positive fentanyl screening kit results during treatment with long term injectable risperidone (Risperdal-Consta).
    Psychiatry Res. 2021;305:114246.
    PubMed     Abstract available

  70. RICHARDSON N, Greenway SC, Bousman CA
    Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.
    Psychiatry Res. 2021;305:114247.
    PubMed     Abstract available

  71. BRASSO C, Cisotto M, Ghirardini C, Pennazio F, et al
    Accuracy of self-reported adherence and therapeutic drug monitoring in a psychiatric emergency ward.
    Psychiatry Res. 2021;305:114214.
    PubMed     Abstract available

  72. GROT S, Giguere CE, Smine S, Mongeau-Perusse V, et al
    Converting scores between the PANSS and SAPS/SANS beyond the positive/negative dichotomy.
    Psychiatry Res. 2021;305:114199.
    PubMed     Abstract available

  73. MILLER BJ, McCall WV, McEvoy JP, Lu XY, et al
    Insomnia and inflammation in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.
    Psychiatry Res. 2021;305:114195.
    PubMed     Abstract available

    October 2021
  74. MENON V, Suhas S, Sethi MIS, Varadharajan N, et al
    Comments on the paper published by Lyu et al on Risk Factors for Suicide in People with Schizophrenia.
    Psychiatry Res. 2021;306:114255.

  75. DAMIANO RF, Avrichir BS, Melzer-Ribeiro DL, Sallet PC, et al
    Which are the best evidence-based therapeutic options for clozapine and ECT resistant schizophrenia? A case-report.
    Psychiatry Res. 2021;305:114248.
    PubMed     Abstract available

  76. PAWELCZYK A, Lojek E, Radek M, Pawelczyk T, et al
    Prosodic deficits and interpersonal difficulties in patients with schizophrenia.
    Psychiatry Res. 2021;306:114244.
    PubMed     Abstract available

  77. LUO X, Zhang L, Zhang J, Chen H, et al
    Changes in the cognitive function of Chinese college students with a clinical high risk of psychosis.
    Psychiatry Res. 2021;305:114242.
    PubMed     Abstract available

  78. CLAYSON PE, Molina JL, Joshi YB, Thomas ML, et al
    Evaluation of the frequency following response as a predictive biomarker of response to cognitive training in schizophrenia.
    Psychiatry Res. 2021;305:114239.
    PubMed     Abstract available

  79. JIANG W, Rootes-Murdy K, Chen J, Bizzozero NIP, et al
    Multivariate alterations in insula - Medial prefrontal cortex linked to genetics in 12q24 in schizophrenia.
    Psychiatry Res. 2021;306:114237.
    PubMed     Abstract available

  80. SANCHEZ MC, Escurriola MF, Sanmartin MIF, Solntseva I, et al
    Cardiovascular disease and mortality in people with schizophrenia or antipsychotic treatment: A cohort study in primary care.
    Psychiatry Res. 2021;306:114233.
    PubMed     Abstract available

  81. BRYCE S, Zbukvic I, Wood SJ, Allott K, et al
    Cognitive remediation to address impairment in schizophrenia: Moving beyond effectiveness and toward implementation.
    Psychiatry Res. 2021;305:114232.

  82. MINICHINO A, Singh F, Pineda J, Friederich E, et al
    Corrigendum to 'Biological Motion induced mu suppression is reduced in Early Psychosis (EP) patients with active negative symptoms and Autism Spectrum Disorders (ASD)' [Psychiatry Research 238 (2016) 374-377].
    Psychiatry Res. 2021;306:114177.

  83. SARZYNSKA-WAWER J, Wawer A, Pawlak A, Szymanowska J, et al
    Detecting formal thought disorder by deep contextualized word representations.
    Psychiatry Res. 2021;304:114135.
    PubMed     Abstract available

    September 2021
  84. LUDTKE T, Ruegg N, Moritz S, Berger T, et al
    Insight and the number of completed modules predict a reduction of positive symptoms in an Internet-based intervention for people with psychosis.
    Psychiatry Res. 2021;306:114223.
    PubMed     Abstract available

  85. ZOU DS, Cowan HR, Azis M, Mittal VA, et al
    Reciprocal Social Behavior and Related Social Outcomes in Individuals at Clinical High Risk for Psychosis.
    Psychiatry Res. 2021;306:114224.
    PubMed     Abstract available

  86. SRIVASTAVA A, Dada O, Qian J, Al-Chalabi N, et al
    Epigenetics of Schizophrenia.
    Psychiatry Res. 2021;305:114218.
    PubMed     Abstract available

  87. FERNANDO R, Gan L, Xiao J, Yun Y, et al
    Hyperprolactinemia induced by brexpiprazole in patients with schizophrenia: A case report.
    Psychiatry Res. 2021;305:114215.

  88. HOMMAN LE, Smart SE, O'Neill F, MacCabe JH, et al
    Attrition in longitudinal studies among patients with schizophrenia and other psychoses; findings from the STRATA collaboration.
    Psychiatry Res. 2021;305:114211.
    PubMed     Abstract available

  89. MISHRA A, Soni AB, Umate MS, Andrade C, et al
    An exploratory evaluation of predictors of duration of untreated psychosis in first-episode psychosis in lower income patients.
    Psychiatry Res. 2021;305:114203.
    PubMed     Abstract available

  90. ZHU L, Zhang W, Zhu Y, Mu X, et al
    Cerebellar theta burst stimulation for the treatment of negative symptoms of schizophrenia: A multicenter, double-blind, randomized controlled trial.
    Psychiatry Res. 2021;305:114204.
    PubMed     Abstract available

  91. SHOSHINA II, Hovis JK, Felisberti FM, Santos NA, et al
    Visual processing and BDNF levels in first-episode schizophrenia.
    Psychiatry Res. 2021;305:114200.
    PubMed     Abstract available

  92. RABINOWITZ J, Rabinowitz AA
    Outlier-response pattern checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).
    Psychiatry Res. 2021;303:114114.
    PubMed     Abstract available

  93. VALERIO KE, Jonas KG, Perlman G, Bromet EJ, et al
    A comparison of cognitive performance in the Suffolk County cohort and their unaffected siblings.
    Psychiatry Res. 2021;303:114111.
    PubMed     Abstract available

    August 2021
  94. KARTALCI S, Erbay MF, Kahraman A, Candir F, et al
    Evaluation of CSF flow dynamics in patients with schizophrenia using phase-contrast cine MRI.
    Psychiatry Res. 2021;304:114172.
    PubMed     Abstract available

  95. REINFELD S, Caceda R, Gil R, Strom H, et al
    Can new onset psychosis occur after mRNA based COVID-19 vaccine administration? A case report.
    Psychiatry Res. 2021;304:114165.

  96. LYU J, Zhang J, Hennessy DA
    Characteristics and Risk Factors for Suicide in People with Schizophrenia in Comparison to Those without Schizophrenia.
    Psychiatry Res. 2021;304:114166.
    PubMed     Abstract available

  97. YANG H, Xiao W, Yang M, Wang Y, et al
    Decreased neuregulin1beta1 in first episode and drug-naive patients with schizophrenia: Negative correlation with cognitive impairment.
    Psychiatry Res. 2021;304:114164.
    PubMed     Abstract available

  98. SAHIN D, Hever F, Bossert M, Herwig K, et al
    Early and middle latency auditory event-related potentials do not explain differences in neuropsychological performance between schizophrenia spectrum patients and matched healthy controls.
    Psychiatry Res. 2021;304:114162.
    PubMed     Abstract available

  99. DAURE C, Fortias M, Icick R, Delage C, et al
    Oral long acting antipsychotic penfluridol as a harm reduction treatment in a patient suffering from untreated schizophrenia and multiple drug dependence: A case report.
    Psychiatry Res. 2021;304:114147.
    PubMed     Abstract available

    July 2021
  100. DA MOTTA C, Pato MT, Barreto Carvalho C, Castilho P, et al
    The neurocognitive and functional profile of schizophrenia in a genetically homogenous European sample.
    Psychiatry Res. 2021;304:114140.
    PubMed     Abstract available

  101. VOPPEL AE, de Boer JN, Brederoo SG, Schnack HG, et al
    Quantified language connectedness in schizophrenia-spectrum disorders.
    Psychiatry Res. 2021;304:114130.
    PubMed     Abstract available

  102. BOSNJAK KUHARIC D, Makaric P, Kekin I, Rossini Gajsak L, et al
    Changes of neurocognitive status in patients with the first-episode psychosis after 18 months of treatment-A prospective cohort study.
    Psychiatry Res. 2021;304:114131.
    PubMed     Abstract available

  103. GRACIA DFK, Gomes EMP, Coelho TA, Carriello M, et al
    Ficolin activation as a potential biomarker of the severity of schizophrenia.
    Psychiatry Res. 2021;304:114122.
    PubMed     Abstract available

  104. KU BS, Pauselli L, Covington MA, Compton MT, et al
    Computational linguistic analysis applied to a semantic fluency task: A replication among first-episode psychosis patients with and without derailment and tangentiality.
    Psychiatry Res. 2021;304:114105.
    PubMed     Abstract available

  105. SNELLEKSZ M, Dean B
    Lower levels of tubulin alpha 1b in the frontal pole in schizophrenia supports a role for changed cytoskeletal dynamics in the aetiology of the disorder.
    Psychiatry Res. 2021;303:114096.
    PubMed     Abstract available

  106. VASKINN A, Engelstad KN, Torgalsboen AK, Rund BR, et al
    Childhood trauma, social cognition and schizophrenia: Specific association between physical neglect and cognitive theory of mind in homicide offenders.
    Psychiatry Res. 2021;303:114093.
    PubMed     Abstract available

  107. JAGADHEESAN K, Danivas V, Itrat Q, Shekaran L, et al
    A 6-month study on the pattern of emergency department presentations for schizophrenia and other psychotic disorders during COVID-19 lockdown.
    Psychiatry Res. 2021;303:114081.
    PubMed     Abstract available

    June 2021
  108. CORBERA S, Wexler BE, Bell MD, Pearlson G, et al
    Predictors of social functioning and quality of life in schizophrenia and autism spectrum disorder.
    Psychiatry Res. 2021;303:114087.
    PubMed     Abstract available

  109. LI S, DeLisi LE, McDonough SI
    Rare germline variants in individuals diagnosed with schizophrenia within multiplex families.
    Psychiatry Res. 2021;303:114038.
    PubMed     Abstract available

  110. CASADO-ORTEGA A, Vila-Badia R, Butjosa A, Del Cacho N, et al
    Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosis.
    Psychiatry Res. 2021;302:114040.
    PubMed     Abstract available

  111. ANDREOU D, Jorgensen KN, Wortinger LA, Engen K, et al
    Cytomegalovirus infection and IQ in patients with severe mental illness and healthy individuals.
    Psychiatry Res. 2021;300:113929.
    PubMed     Abstract available

  112. BRAUN D, Schlossmann J, Haen E
    Asymmetric dimethylarginine in psychiatric disorders.
    Psychiatry Res. 2021;300:113901.
    PubMed     Abstract available

    May 2021
  113. KELLY DL, Claxton A, Bidollari I, Du Y, et al
    Analysis of prolactin and sexual side effects in patients with schizophrenia who switched from paliperidone palmitate to aripiprazole lauroxil.
    Psychiatry Res. 2021;302:114030.
    PubMed     Abstract available

  114. GUILLAUME F, Thomas E
    Recollection and familiarity in schizophrenia:An ERP investigation using face recognition exclusion tasks.
    Psychiatry Res. 2021;302:113973.
    PubMed     Abstract available

  115. SCHEFFLER F, Phahladira L, Luckhoff H, du Plessis S, et al
    Cannabis use and clinical outcome in people with first-episode schizophrenia spectrum disorders over 24 months of treatment.
    Psychiatry Res. 2021;302:114022.
    PubMed     Abstract available

  116. MUNOZ-SAMONS D, Tor J, Rodriguez-Pascual M, Alvarez-Subiela X, et al
    Recent stressful life events and stress sensitivity in children and adolescents at clinical risk for psychosis.
    Psychiatry Res. 2021;303:114017.
    PubMed     Abstract available

  117. HELLER C, Weiss T, Del Re EC, Swago S, et al
    Smaller subcortical volumes and enlarged lateral ventricles are associated with higher global functioning in young adults with 22q11.2 deletion syndrome with prodromal symptoms of schizophrenia.
    Psychiatry Res. 2021;301:113979.
    PubMed     Abstract available

  118. ABEL DB, Salyers MP, Wu W, Monette MA, et al
    Quality versus quantity: Determining real-world social functioning deficits in schizophrenia.
    Psychiatry Res. 2021;301:113980.
    PubMed     Abstract available

    April 2021
  119. ALBA L, Coll C, Saez S, Alonso L, et al
    New-onset psychosis: A case report of brief psychosis related to COVID-19 infection.
    Psychiatry Res. 2021;301:113975.

  120. UCOK A, Karakas B, Sahin OS
    Formal thought disorder in patients with first-episode schizophrenia: Results of a one-year follow-up study.
    Psychiatry Res. 2021;301:113972.
    PubMed     Abstract available

  121. Discrepancies between staff and gold standard ratings of schizophrenia symptom severity.
    Psychiatry Res. 2021;301:113963.

  122. DE PERI L, Deste G, Vita A
    Strucutural brain imaging at the onset of schizophrenia:What have we learned and what have we missed.
    Psychiatry Res. 2021;301:113962.
    PubMed     Abstract available

  123. MEDALIA A, Saperstein AM, Stefancic A, Meyler S, et al
    Feasibility and acceptability of remotely accessed cognitive remediation for schizophrenia in public health settings.
    Psychiatry Res. 2021;301:113956.
    PubMed     Abstract available

  124. XIE YJ, Xi YB, Cui LB, Guan MZ, et al
    Functional connectivity of cerebellar dentate nucleus and cognitive impairments in patients with drug-naive and first-episode schizophrenia.
    Psychiatry Res. 2021;300:113937.
    PubMed     Abstract available

  125. PENNOU A, Lecomte T, Khazaal Y, Potvin S, et al
    Does theory of mind predict specific domains of social functioning in individuals following a first episode psychosis?
    Psychiatry Res. 2021;301:113933.
    PubMed     Abstract available

  126. WANG YY, Hsu SH, Tsai HY, Cheng MC, et al
    Sequencing of the coding regions of GNBIL on chromosome 22q11.2 as a risk gene of schizophrenia.
    Psychiatry Res. 2021;300:113943.
    PubMed     Abstract available

  127. SCHURHOFF F, Corfdir C, Pignon B, Lajnef M, et al
    No alteration of leukocyte telomere length in first episode psychosis.
    Psychiatry Res. 2021;301:113941.
    PubMed     Abstract available

  128. VAERNES TG, Rossberg JI, Melle I, Nelson B, et al
    Basic self-disturbance in subjects at clinical high risk for psychosis: Relationship with clinical and functional outcomes at one year follow-up.
    Psychiatry Res. 2021;300:113942.
    PubMed     Abstract available

  129. STRASSNIG MT, Miller ML, Moore R, Depp CA, et al
    Evidence for avolition in bipolar disorder? A 30-day ecological momentary assessment comparison of daily activities in bipolar disorder and schizophrenia.
    Psychiatry Res. 2021;300:113924.
    PubMed     Abstract available

  130. SIDDIQUI SV, Nizamie SH, Siddiqui MA, Jahan M, et al
    Evaluation of N-400 Evoked Response Potential in schizophrenia: An endophenotype or a disease marker?
    Psychiatry Res. 2021;300:113907.
    PubMed     Abstract available

    March 2021
  131. AU RWC, Sezto HNW, Lam VWM, Wan YT, et al
    Brief report: A randomized controlled trial of a compensatory cognitive training to improve prospective memory performance in people with schizophrenia or depression.
    Psychiatry Res. 2021;300:113914.
    PubMed     Abstract available

  132. LI M, Liu Y, Qiu Y, Zhang J, et al
    The effect of berberine adjunctive treatment on glycolipid metabolism in patients with schizophrenia: A randomized, double-blind, placebo-controlled clinical trial.
    Psychiatry Res. 2021;300:113899.
    PubMed     Abstract available

  133. GAN H, Zhu J, Zhuo K, Zhang J, et al
    High frequency repetitive transcranial magnetic stimulation of dorsomedial prefrontal cortex for negative symptoms in patients with schizophrenia: A double-blind, randomized controlled trial.
    Psychiatry Res. 2021;299:113876.
    PubMed     Abstract available

  134. PAN Z, Xiong D, Xiao H, Li J, et al
    The Effects of Repetitive Transcranial Magnetic Stimulation in Patients with Chronic Schizophrenia: Insights from EEG Microstates.
    Psychiatry Res. 2021;299:113866.
    PubMed     Abstract available

  135. LUCKHOFF HK, Asmal L, Scheffler F, du Plessis S, et al
    Gender role endorsement in first-episode schizophrenia spectrum disorders.
    Psychiatry Res. 2021;299:113867.
    PubMed     Abstract available

  136. YANG F, Ma H, Yuan J, Wei Y, et al
    Correlation of abnormalities in resting state fMRI with executive functioning in chronic schizophrenia.
    Psychiatry Res. 2021;299:113862.
    PubMed     Abstract available

  137. BERTRAND T, Tavitian A, Galindez JM, Kothari V, et al
    Heme oxygenase-1 in blood and saliva during acute psychosis: A pilot study.
    Psychiatry Res. 2021;299:113857.
    PubMed     Abstract available

  138. PARK HJ, Kang WS, Kim JW
    Association between the promoter haplotype of RTN4 gene and schizophrenia in a Korean population.
    Psychiatry Res. 2021;299:113841.
    PubMed     Abstract available

  139. BIAN Y, Lin C, Ma B, Han X, et al
    Effect of subjective sleep quality on learning and memory in drug-free patients with schizophrenia.
    Psychiatry Res. 2021;299:113849.
    PubMed     Abstract available

  140. CANTY AL, Cao Y, Neumann D, Shum DHK, et al
    The functional significance of cognitive empathy and theory of mind in early and chronic schizophrenia.
    Psychiatry Res. 2021;299:113852.
    PubMed     Abstract available

  141. SIMON AE, Keller P, Cattapan K
    Commentary about social avoidance and its significance in adolescents and young adults.
    Psychiatry Res. 2021;297:113718.
    PubMed     Abstract available

  142. TOYODA K, Hata T, Yamauchi S, Kinoshita S, et al
    A descriptive study of 10-year clozapine use from the nationwide database in Japan.
    Psychiatry Res. 2021;297:113764.
    PubMed     Abstract available

  143. O'CONNOR C, Vaughan S
    Does selectively endorsing different approaches to treating mental illness affect lay beliefs about the cause and course of mental illness?
    Psychiatry Res. 2021;297:113726.
    PubMed     Abstract available

    February 2021
  144. CRUZ BF, de Campos-Carli SM, de Oliveira AM, de Brito CB, et al
    Investigating potential associations between neurocognition/social cognition and oxidative stress in schizophrenia.
    Psychiatry Res. 2021;298:113832.
    PubMed     Abstract available

  145. GOGOS A, Sun J, Udawela M, Gibbons A, et al
    Cortical expression of the RAPGEF1 gene in schizophrenia: investigating regional differences and suicide.
    Psychiatry Res. 2021;298:113818.
    PubMed     Abstract available

  146. BELVEDERI MURRI M, Zotos S, Cantarelli L, Berardi L, et al
    Between China and Italy: A case report of first-episode schizophrenia in the Covid-19 era.
    Psychiatry Res. 2021;298:113804.

  147. ESPOSITO CM, D'Agostino A, Dell Osso B, Fiorentini A, et al
    Impact of the first Covid-19 pandemic wave on first episode psychosis in Milan, italy.
    Psychiatry Res. 2021;298:113802.
    PubMed     Abstract available

  148. BJORKLY S, Laake P, Roaldset JO, Douglas KS, et al
    The Safe pilot study: A prospective naturalistic study with repeated measures design to test the psychosis - violence link in and after discharge from forensic facilities.
    Psychiatry Res. 2021;298:113793.
    PubMed     Abstract available

  149. RENDON-QUINTERO E, Ortiz K, Vallejo Silva A
    SCHIZOPHRENIA in the midst of a COVID-19 outbreak in a psychiatric hospital in COLOMBIA.
    Psychiatry Res. 2021;298:113785.
    PubMed     Abstract available

  150. BERNARDIN F, Schwitzer T, Angioi-Duprez K, Giersch A, et al
    Retinal ganglion cell dysfunction is correlated with disturbed visual cognition in schizophrenia patients with visual hallucinations.
    Psychiatry Res. 2021;298:113780.
    PubMed     Abstract available

  151. SREERAJ VS, Holla B, Ithal D, Nadella RK, et al
    Psychiatric symptoms and syndromes transcending diagnostic boundaries in Indian multiplex families: The cohort of ADBS study.
    Psychiatry Res. 2021;296:113647.
    PubMed     Abstract available

  152. MORRIS E, Batallones R, Ryan J, Slomp C, et al
    Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
    Psychiatry Res. 2021;296:113663.
    PubMed     Abstract available

  153. CAMUS D, Dan Glauser ES, Gholamrezaee M, Gasser J, et al
    Factors associated with repetitive violent behavior of psychiatric inpatients.
    Psychiatry Res. 2021;296:113643.
    PubMed     Abstract available

  154. GURCAN G, Senol SH, Yagcioglu AEA, Ertugrul A, et al
    Clinical risk factors, phenomenology and the impact of clozapine induced obsessive compulsive symptoms.
    Psychiatry Res. 2021;296:113665.
    PubMed     Abstract available

  155. KHARE C, Mueser KT, Bahaley M, Vax S, et al
    Employment in people with severe mental illnesses receiving public sector psychiatric services in India.
    Psychiatry Res. 2021;296:113673.
    PubMed     Abstract available

    January 2021
  156. PHAHLADIRA L, Asmal L, Luckhoff HK, du Plessis S, et al
    The course and concomitants of depression in first-episode schizophrenia spectrum disorders: A 24-month longitudinal study.
    Psychiatry Res. 2021;298:113767.
    PubMed     Abstract available

  157. GOSEK P, Kotowska J, Rowinska-Garbien E, Bartczak D, et al
    Treatment resistance and prolonged length of stay among schizophrenia inpatients in forensic institutions.
    Psychiatry Res. 2021;298:113771.
    PubMed     Abstract available

  158. TRONCHIN G, McPhilemy G, Ahmed M, Kilmartin L, et al
    White matter microstructure and structural networks in treatment-resistant schizophrenia patients after commencing clozapine treatment: A longitudinal diffusion imaging study.
    Psychiatry Res. 2021;298:113772.
    PubMed     Abstract available

  159. KLAUS F, Guetter K, Schlegel R, Seifritz E, et al
    Peripheral biopterin and neopterin in schizophrenia and depression.
    Psychiatry Res. 2021;297:113745.
    PubMed     Abstract available

  160. MOTA P
    "I have no disease and weed just relaxes me!": The therapeutic challenge in young patients with psychosis and cannabis abuse.
    Psychiatry Res. 2021;297:113741.

  161. LUCA P, Rafael T, Emilio B, Antonio V, et al
    Are Schizophrenic disorders with or without early cannabis use neurobiologically distinct disease entities? A meta-analysis of magnetic resonance imaging studies.
    Psychiatry Res. 2021;297:113731.
    PubMed     Abstract available

  162. ZAHID A, Best MW
    Stigma towards individuals with schizophrenia: Examining the effects of negative symptoms and diagnosis awareness on preference for social distance.
    Psychiatry Res. 2021;297:113724.
    PubMed     Abstract available

  163. CHEN D, Li H, Zhao Q, Song J, et al
    Effect of risperidone treatment on insulin-like growth factor-1 and interleukin-17 in drug naive first-episode schizophrenia.
    Psychiatry Res. 2021;297:113717.
    PubMed     Abstract available

  164. FATTAHI C, Hamada K, Chiang M, Kosuru S, et al
    A narrative review of mindfulness-based therapy for schizophrenia, co-occurring substance use and comorbid cardiometabolic problems.
    Psychiatry Res. 2021;296:113707.
    PubMed     Abstract available

  165. SERRA-MAYORAL A, Mareca C, Cano R, Romaguera A, et al
    The BAT: A videotaped battery to assess theory of mind in schizophrenia.
    Psychiatry Res. 2021;297:113709.
    PubMed     Abstract available

  166. SELVARAJ S, Chhabra H, Dinakaran D, Sreeraj VS, et al
    Auditory signal detection in schizophrenia: Correlates with auditory verbal hallucinations & effect of single session transcranial direct current stimulation (tDCS).
    Psychiatry Res. 2021;297:113704.
    PubMed     Abstract available

  167. SEILER N, Hunter J, Waterdrinker A, Das S, et al
    Psychopathological consequences of the COVID-19 pandemic: A case report of psychosis.
    Psychiatry Res. 2021;296:113703.

  168. KETHARANATHAN T, Pereira A, Reets U, Walker D, et al
    Brain changes in NF-kappaB1 and epidermal growth factor system markers at peri-pubescence in the spiny mouse following maternal immune activation.
    Psychiatry Res. 2021;295:113564.
    PubMed     Abstract available

    December 2020
  169. MARTINI F, Spangaro M, Buonocore M, Bechi M, et al
    Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex.
    Psychiatry Res. 2020;297:113698.
    PubMed     Abstract available

  170. ROSEBROCK LE, Waite F, Diamond R, Collett N, et al
    Anticipatory pleasure in current psychosis: Cognitive and emotional correlates.
    Psychiatry Res. 2020;297:113697.
    PubMed     Abstract available

  171. MAAGENSEN H, Larsen JR, Jorgensen NR, Fink-Jensen A, et al
    Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes - randomized controlled trial.
    Psychiatry Res. 2020;296:113670.
    PubMed     Abstract available

  172. LIU Y, Gu N, Cao X, Zhu Y, et al
    Effects of transcranial electrical stimulation on working memory in patients with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;296:113656.
    PubMed     Abstract available

  173. DADA O, Adanty C, Dai N, Jeremian R, et al
    Biological aging in schizophrenia and psychosis severity: DNA methylation analysis.
    Psychiatry Res. 2020;296:113646.
    PubMed     Abstract available

  174. NG QX, Chong JWX, Yong CSK, Sivalingam V, et al
    Re-considering the use of bupropion in schizophrenia: A case report and review of literature.
    Psychiatry Res. 2020;295:113636.

  175. SURMANN M, Falke S, von Gruchalla L, Maisch B, et al
    Understanding the multidimensional phenomenon of medication adherence attitudes in psychosis.
    Psychiatry Res. 2020;295:113601.
    PubMed     Abstract available

  176. MAHMOOD Z, Van Patten R, Keller AV, Lykins HC, et al
    Reducing negative symptoms in schizophrenia: Feasibility and acceptability of a combined cognitive-behavioral social skills training and compensatory cognitive training intervention.
    Psychiatry Res. 2020;295:113620.
    PubMed     Abstract available

    November 2020
  177. STEFANOVA M, Taylor G, Jacobsen P
    Who gets evidence-based therapy for psychosis following a psychiatric hospital admission? Follow-up data from an inpatient randomised controlled trial.
    Psychiatry Res. 2020;295:113605.
    PubMed     Abstract available

  178. THOMAS M, Szentgyorgyi T, Vanes LD, Mouchlianitis E, et al
    Cognitive performance in early, treatment-resistant psychosis patients: Could cognitive control play a role in persistent symptoms?
    Psychiatry Res. 2020;295:113607.
    PubMed     Abstract available

  179. TOUS-ESPELOSIN M, de Azua SR, Iriarte-Yoller N, MartinezAguirre-Betolaza A, et al
    Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study: Characterization of adults with schizophrenia.
    Psychiatry Res. 2020 Nov 18:113580. doi: 10.1016/j.psychres.2020.113580.
    PubMed     Abstract available

  180. PENG Y, Zhang S, Zhou Y, Song Y, et al
    Abnormal functional connectivity based on nodes of the default mode network in first-episode drug-naive early-onset schizophrenia.
    Psychiatry Res. 2020 Nov 18:113578. doi: 10.1016/j.psychres.2020.113578.
    PubMed     Abstract available

  181. DELISI LE
    A commentary revisiting the viral hypothesis of schizophrenia: Onset of a schizophreniform disorder subsequent to SARS CoV-2 infection.
    Psychiatry Res. 2020 Nov 16:113573. doi: 10.1016/j.psychres.2020.113573.
    PubMed     Abstract available

  182. HOPKINS SC, Ogirala A, Loebel A, Koblan KS, et al
    Characterization of specific and distinct patient types in clinical trials of acute schizophrenia using an uncorrelated PANSS score matrix transform (UPSM).
    Psychiatry Res. 2020 Nov 11:113569. doi: 10.1016/j.psychres.2020.113569.
    PubMed     Abstract available

  183. PALOMAR-CIRIA N, Alonso-Alvarez D, Vazquez-Beltran P, Blanco Del Valle P, et al
    Commentary to "Schizophrenia and COVID-19 Delirium", an update.
    Psychiatry Res. 2020;294:113555.

  184. GUIDARA W, Messedi M, Naifar M, Maalej M, et al
    Predictive value of oxidative stress biomarkers in drugfree patients with schizophrenia and schizo-affective disorder.
    Psychiatry Res. 2020;293:113467.
    PubMed     Abstract available

  185. LOU S, Xue X
    Application of electroencephalographic (EEG) biofeedback therapy in the rehabilitation of patients with chronic diseases.
    Psychiatry Res. 2020;293:113371.
    PubMed     Abstract available

    October 2020
  186. PELIZZA L, Maestri D, Leuci E, Quattrone E, et al
    Negative symptom configuration within and outside schizophrenia spectrum disorders: results from the "Parma Early Psychosis" program.
    Psychiatry Res. 2020;294:113519.
    PubMed     Abstract available

  187. GRIMES KM DR, Foussias G, Remington G, Kalahani-Bargis K, et al
    Stability of Verbal Fluency in Outpatients with Schizophrenia.
    Psychiatry Res. 2020 Oct 23:113528. doi: 10.1016/j.psychres.2020.113528.
    PubMed     Abstract available

  188. GRATTAN RE, Tryon VL, Carter CS, Niendam TA, et al
    Suicide behavior is associated with childhood emotion dysregulation but not trait impulsivity in first episode psychosis.
    Psychiatry Res. 2020;294:113517.
    PubMed     Abstract available

  189. AJNAKINA O, Agbedjro D, Lally J, Forti MD, et al
    Predicting onset of early- and late-treatment resistance in first-episode schizophrenia patients using advanced shrinkage statistical methods in a small sample.
    Psychiatry Res. 2020;294:113527.
    PubMed     Abstract available

  190. SIMOILA L, Isometsa E, Gissler M, Suvisaari J, et al
    Pregnancy, delivery and postpartum in women with schizophrenia or schizoaffective disorder in Finland: a national register-based comparative study.
    Psychiatry Res. 2020;294:113504.
    PubMed     Abstract available

  191. SCOTT M, Rossell SL, Toh WL, Thomas N, et al
    The relationship between anxiety, depression, and subtypes of negative auditory verbal hallucination (AVH) content in affective and non-affective psychosis.
    Psychiatry Res. 2020;294:113500.
    PubMed     Abstract available

  192. MCGOVERN JE, Masucci MD, Le TP, Cohen AS, et al
    The (b)link between amotivation and psychosis: Insights through phasic eye blink rate.
    Psychiatry Res. 2020;294:113490.
    PubMed     Abstract available

  193. RANDERS L, Fagerlund B, Jepsen JRM, Nordholm D, et al
    Interview and questionnaire assessment of cognitive impairment in subjects at ultra-high risk for psychosis: Associations with cognitive test performance, psychosocial functioning, and positive symptoms.
    Psychiatry Res. 2020;294:113498.
    PubMed     Abstract available

  194. KELLY DL, Spaderna M, Hodzic V, Nair S, et al
    Blinded Clinical Ratings of Social Media Data are Correlated with In-Person Clinical Ratings in Participants Diagnosed with Either Depression, Schizophrenia, or Healthy Controls.
    Psychiatry Res. 2020;294:113496.
    PubMed     Abstract available

  195. TALIERCIO J, Bonasera B, Portillo C, Ramjas E, et al
    Physical Activity, Sleep-related Behaviors and Severity of Symptoms in Schizophrenia.
    Psychiatry Res. 2020;294:113489.
    PubMed     Abstract available

  196. SCHUTTE MJL, Linszen MMJ, Marschall TM, Ffytche DH, et al
    Hallucinations and other psychotic experiences across diagnoses: A comparison of phenomenological features.
    Psychiatry Res. 2020;292:113314.
    PubMed     Abstract available

    September 2020
  197. MA C, Li Y, Li X, Liu J, et al
    Identification of a functional SNP rs7304782 at schizophrenia risk locus 12q24.31 and validation of its association with schiz ophrenia in Chinese populations.
    Psychiatry Res. 2020;294:113491.
    PubMed     Abstract available

  198. YAN P, Song M, Gao B, Wang S, et al
    Association of the genetic polymorphisms of metabolizing enzymes, transporters, target receptors and their interactions with treatment response to olanzapine in chinese han schizophrenia patients.
    Psychiatry Res. 2020;293:113470.
    PubMed     Abstract available

  199. JIA R, Liang D, Yu J, Lu G, et al
    The effectiveness of adjunct music therapy for patients with schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;293:113464.
    PubMed     Abstract available

  200. CUI Y, Piao Y, Kim SW, Lee BJ, et al
    Psychological factors intervening between childhood trauma and suicidality in first-episode psychosis.
    Psychiatry Res. 2020;293:113465.
    PubMed     Abstract available

  201. CAO B, Chen Y, McIntyre RS, Yan L, et al
    Acyl-Carnitine plasma levels and their association with metabolic syndrome in individuals with schizophrenia.
    Psychiatry Res. 2020;293:113458.
    PubMed     Abstract available

  202. BEN AFIA A, Aflouk Y, Saoud H, Zaafrane F, et al
    Inteurleukin-8 gene variations and the susceptibility to schizophrenia.
    Psychiatry Res. 2020;293:113421.
    PubMed     Abstract available

  203. HATANO M, Kamei H, Shimato A, Yamada S, et al
    Trend survey on adverse event profiles of antipsychotic long-acting injections and oral agents using the Japanese adverse drug event report database.
    Psychiatry Res. 2020;291:113249.
    PubMed     Abstract available

  204. KATINA S, Kelly BD, Rojas MA, Sukno FM, et al
    Refining the resolution of craniofacial dysmorphology in bipolar disorder as an index of brain dysmorphogenesis.
    Psychiatry Res. 2020;291:113243.
    PubMed     Abstract available

  205. PEREDO R, Gagne AM, Gilbert E, Hebert M, et al
    Electroretinography may reveal cognitive impairment among a cohort of subjects at risk of a major psychiatric disorder.
    Psychiatry Res. 2020;291:113227.
    PubMed     Abstract available

  206. LANGLOIS T, Sanchez-Rodriguez R, Bourcier A, Lamy P, et al
    Impact of the group intervention "Accept Voices(c)" for the management of auditory hallucinations.
    Psychiatry Res. 2020;291:113159.
    PubMed     Abstract available

    August 2020
  207. MELAMED SB, Farfel A, Gur S, Krivoy A, et al
    Thyroid function assessment before and after diagnosis of schizophrenia: A community-based study.
    Psychiatry Res. 2020;293:113356.
    PubMed     Abstract available

  208. ADAMS SW, Yanos PT
    Pathways to aggression and violence in psychosis without longstanding antisocial behavior: A review and proposed psychosocial model for integrative clinical interventions.
    Psychiatry Res. 2020;293:113427.
    PubMed     Abstract available

  209. DE VOS C, Leopold K, Blanke ES, Siebert S, et al
    The relationship between cannabis use and cognition in people diagnosed with first-episode psychosis.
    Psychiatry Res. 2020;293:113424.
    PubMed     Abstract available

  210. SHANNON A, McGuire D, Brown E, O'Donoghue B, et al
    A systematic review of the effectiveness of group-based exercise interventions for individuals with first episode psychosis.
    Psychiatry Res. 2020;293:113402.
    PubMed     Abstract available

  211. CUESTA MJ, Sanchez-Torres AM, Lorente-Omenaca R, Zandio M, et al
    Validity and utility of a set of clinical criteria for cognitive impairment associated with psychosis (CIAPs).
    Psychiatry Res. 2020;293:113404.
    PubMed     Abstract available

  212. PROKOPEZ CR, Vallejos M, Farinola R, Alberio G, et al
    The history of multiple adverse childhood experiences in patients with schizophrenia is associated with more severe symptomatology and suicidal behavior with gender-specific characteristics.
    Psychiatry Res. 2020;293:113411.
    PubMed     Abstract available

  213. STRASSNIG M, Jones MT, Pinkham A, Penn D, et al
    Depression, hostility, attributional biases, and paranoia in schizophrenia and healthy controls: intercorrelations and associations with self-assessment of social functioning.
    Psychiatry Res. 2020;293:113388.

  214. WANG YY, Hsu SH, Tsai HY, Cheng MC, et al
    Genetic analysis of the NR2E1 gene as a candidate gene of schizophrenia.
    Psychiatry Res. 2020;293:113386.
    PubMed     Abstract available

  215. GIBSON CL, Bassir Nia A, Spriggs SA, DeFrancisco D, et al
    Cannabinoid use in psychotic patients impacts inflammatory levels and their association with psychosis severity.
    Psychiatry Res. 2020;293:113380.
    PubMed     Abstract available

  216. BOKA E, Pozzo JD, Goetz D, Remsen B, et al
    Ineffective risk-reward learning in schizophrenia.
    Psychiatry Res. 2020;293:113370.
    PubMed     Abstract available

  217. WAMBUA GN, Kilian S, Ntlantsana V, Chiliza B, et al
    The association between resilience and psychosocial functioning in schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;293:113374.
    PubMed     Abstract available

  218. LIN X, Deng J, Dong G, Li S, et al
    Effects of Chronic Pharmacological Treatment on Functional Brain Network Connectivity in Patients with Schizophrenia.
    Psychiatry Res. 2020 Aug 4:113338. doi: 10.1016/j.psychres.2020.113338.
    PubMed     Abstract available

  219. GRIGORIOU M, Upthegrove R
    Blunted affect and suicide in schizophrenia: A systematic review.
    Psychiatry Res. 2020;293:113355.
    PubMed     Abstract available

  220. JENSEN RAA, Thomsen DK, Bliksted VF, Ladegaard N, et al
    Narrative Identity in Psychopathology: A Negative Past and a Bright but Foreshortened Future.
    Psychiatry Res. 2020;290:113103.
    PubMed     Abstract available

  221. LALOYAUX J, Collazzoni A, Hirnstein M, Kusztrits I, et al
    Personal resilience factors protect against distressing auditory hallucinations: A study comparing psychotic patients with auditory hallucinations, non-patients with auditory hallucinations, and healthy controls.
    Psychiatry Res. 2020;290:113058.
    PubMed     Abstract available

    July 2020
  222. CULLEN BA, Rodriguez K, Eaton WW, Mojtabai R, et al
    Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study.
    Psychiatry Res. 2020;292:113346.
    PubMed     Abstract available

  223. CAQUEO-URIZAR A, Ferrer R, Ponce F, Urzua A, et al
    Clinical outcomes of schizophrenia: A differential study among Latin-American countries.
    Psychiatry Res. 2020;292:113334.

  224. QING L, Liu L, Zhou L, Zhang F, et al
    Sex-dependent association of mineralocorticoid receptor gene (NR3C2) DNA methylation and schizophrenia.
    Psychiatry Res. 2020;292:113318.
    PubMed     Abstract available

  225. PU J, Liu Y, Gui S, Tian L, et al
    Vascular endothelial growth factor in major depressive disorder, schizophrenia, and bipolar disorder: A network meta-analysis.
    Psychiatry Res. 2020;292:113319.
    PubMed     Abstract available

  226. OHAYON S, Yitzhaky A, Hertzberg L
    Gene expression meta-analysis reveals the up-regulation of CREB1 and CREBBP in Brodmann Area 10 of patients with schizophrenia.
    Psychiatry Res. 2020;292:113311.
    PubMed     Abstract available

  227. HE Q, You Y, Yu L, Yao L, et al
    Uric acid levels in subjects with schizophrenia: A systematic review and meta-analysis.
    Psychiatry Res. 2020;292:113305.
    PubMed     Abstract available

  228. CEYLAN D, Akdede BB, Bora E, Aktener AY, et al
    Neurocognitive functioning during symptomatic states and remission in bipolar disorder and schizophrenia: A comparative study.
    Psychiatry Res. 2020;292:113292.
    PubMed     Abstract available

  229. KEZAI AM, Lecoeur C, Hot D, Bounechada M, et al
    Association between schizophrenia and Toxoplasma gondii infection in Algeria.
    Psychiatry Res. 2020;291:113293.
    PubMed     Abstract available

  230. FIERINI F, Moretti D, Ballerini A
    Psychosis spectrum disorders during and after the COVID-19 pandemic: Warning signs of "stress incubation".
    Psychiatry Res. 2020;291:113291.

  231. OLUWOYE O, Stokes B, Stiles B, Monroe-DeVita M, et al
    Understanding differences in family engagement and provider outreach in New Journeys: A coordinated specialty care program for first episode psychosis.
    Psychiatry Res. 2020;291:113286.
    PubMed     Abstract available

  232. KOOLA MM, Looney SW, Hong H, Pillai A, et al
    Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement.
    Psychiatry Res. 2020;291:113285.
    PubMed     Abstract available

  233. FORTGANG RG, Hoff RA, Potenza MN
    Schizophrenia symptom severity and motivations for gambling in individuals with schizophrenia or schizoaffective disorder.
    Psychiatry Res. 2020;291:113281.
    PubMed     Abstract available

  234. KONJEVOD M, Nikolac Perkovic M, Svob Strac D, Uzun S, et al
    Significant association of mu-opioid receptor 1 haplotype with tobacco smoking in healthy control subjects but not in patients with schizophrenia and alcohol dependence.
    Psychiatry Res. 2020;291:113278.
    PubMed     Abstract available

  235. KERN RS, Reddy LF, Cohen AN, Young AS, et al
    Effects of aerobic exercise on cardiorespiratory fitness and social functioning in veterans 40 to 65 years old with schizophrenia.
    Psychiatry Res. 2020;291:113258.
    PubMed     Abstract available

  236. SUMNER PJ, Carruthers SP, Rossell SL
    Examining Self-Reported Thought Disorder: Continuous Variation, Convergence with Schizotypy, and Cognitive Correlates.
    Psychiatry Res. 2020;289:112943.
    PubMed     Abstract available

    June 2020
  237. PAN R, Zhang X, Gao J, Yi W, et al
    Analysis of the diversity of intestinal microbiome and its potential value as a biomarker in patients with schizophrenia: A cohort study.
    Psychiatry Res. 2020;291:113260.
    PubMed     Abstract available

  238. KOPELLI E, Samara M, Siargkas A, Goulas A, et al
    The role of cannabidiol oil in schizophrenia treatment. a systematic review and meta-analysis.
    Psychiatry Res. 2020;291:113246.
    PubMed     Abstract available

  239. DICKERSON F, Schroeder JR, Nimgaonkar V, Gold J, et al
    The association between exposure to herpes simplex virus type 1 (HSV-1) and cognitive functioning in schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;291:113157.
    PubMed     Abstract available

  240. MOSCHOPOULOS N, Nimatoudis I, Kaprinis S, Sidiras C, et al
    Auditory processing disorder may be present in schizophrenia and it is highly correlated with formal thought disorder.
    Psychiatry Res. 2020;291:113222.
    PubMed     Abstract available

  241. VUKOJEVIC J, Susac J, Brecic P
    Psychosis and pandemics: Is there a secret protector?
    Psychiatry Res. 2020;291:113199.

  242. MENEGHELLI A, Barbera S, Meliante M, Monzani E, et al
    Outcome at 2-year of treatment in first-episode psychosis patients who were enrolled in a specialized early intervention program.
    Psychiatry Res. 2020;291:113200.
    PubMed     Abstract available

  243. HAGEN JM, Sutterland AL, Edrisy S, Tan HL, et al
    Accumulation rate of advanced glycation end products in recent onset psychosis: A longitudinal study.
    Psychiatry Res. 2020;291:113192.
    PubMed     Abstract available

  244. LYSAKER PH, Chernov N, Moiseeva T, Sozinova M, et al
    Contrasting metacognitive profiles and their association with negative symptoms in groups with schizophrenia, early psychosis and depression in a Russian sample.
    Psychiatry Res. 2020;291:113177.
    PubMed     Abstract available

  245. HOLZLE P, Aly L, Frank W, Forstl H, et al
    COVID-19 distresses the depressed while schizophrenic patients are unimpressed: A study on psychiatric inpatients.
    Psychiatry Res. 2020;291:113175.

  246. ZHAND N, Osborne R, Stuyt M, Hatko A, et al
    Incidental finding of age and time disorientation in a clinical sample of patients with schizophrenia: Findings from a short term follow up survey regarding cannabis use.
    Psychiatry Res. 2020;290:113150.
    PubMed     Abstract available

  247. TOH WL, Thomas N, Hollander Y, Rossell SL, et al
    On the phenomenology of auditory verbal hallucinations in affective and non-affective psychosis.
    Psychiatry Res. 2020;290:113147.
    PubMed     Abstract available

  248. MICHAEL GA, Dorey JM, Rey R, D'Amato T, et al
    Attention in schizophrenia: Impaired inhibitory control, faulty attentional resources, or both?
    Psychiatry Res. 2020;290:113164.
    PubMed     Abstract available

  249. COOK JA, Burke-Miller JK, Jonikas JA, Aranda F, et al
    Factors associated with 30-day readmissions following medical hospitalizations among Medicaid beneficiaries with schizophrenia, bipolar disorder, and major depressive disorder.
    Psychiatry Res. 2020;291:113168.
    PubMed     Abstract available

    May 2020
    Commentary on "Psychosis associated to CASPR2 autoantibodies and ovarian teratoma: A case report".
    Psychiatry Res. 2020;290:113144.

  251. MAVROGIORGOU P, Haller K, Juckel G
    Death anxiety and attitude to death in patients with schizophrenia and depression.
    Psychiatry Res. 2020;290:113148.
    PubMed     Abstract available

  252. LI J, Cao X, Liu S, Li X, et al
    Efficacy of repetitive transcranial magnetic stimulation on auditory hallucinations in schizophrenia: A meta-analysis.
    Psychiatry Res. 2020;290:113141.
    PubMed     Abstract available

  253. KHOBRAGADE B, Sharma V, Deshpande SN
    A study on tobacco use in women with major mental illnesses- schizophrenia, bipolar disorder and recurrent depression.
    Psychiatry Res. 2020;290:113121.
    PubMed     Abstract available

  254. PALOMAR-CIRIA N, Blanco Del Valle P, Hernandez-Las Heras MA, Martinez-Gallardo R, et al
    Schizophrenia and COVID-19 delirium.
    Psychiatry Res. 2020;290:113137.
    PubMed     Abstract available

  255. CHANDRA PS, Shiva L, Nagendrappa S, Ganjekar S, et al
    COVID 19 related Psychosis as an interface of fears, socio-cultural issues and vulnerability- case report of two women from India.
    Psychiatry Res. 2020;290:113136.

  256. VALERY KM, Prouteau A
    Schizophrenia stigma in mental health professionals and associated factors: A systematic review.
    Psychiatry Res. 2020;290:113068.
    PubMed     Abstract available

  257. SREERAJ VS, Suhas S, Parlikar R, Selvaraj S, et al
    Effect of add-on transcranial alternating current stimulation (tACS) on persistent delusions in schizophrenia.
    Psychiatry Res. 2020;290:113106.
    PubMed     Abstract available

  258. SAKANAKA S, Tsujii N, Morimoto H, Shirakawa O, et al
    Aggressiveness is associated with excitement on the five-factor model of the positive and negative syndrome scale and prefrontal function in patients with stable schizophrenia.
    Psychiatry Res. 2020;290:113054.
    PubMed     Abstract available

  259. CORREA-PALACIO AF, Hernandez-Huerta D, Gomez-Arnau J, Loeck C, et al
    Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.
    Psychiatry Res. 2020;290:113115.

  260. KANG Y, Huang K, Lin Y, Xu H, et al
    Abnormalities of effective connectivity and white matter microstructure in the triple network in patients with schizophrenia.
    Psychiatry Res. 2020;290:113019.
    PubMed     Abstract available

  261. VEGA-SEVEY JG, Martinez-Magana JJ, Genis-Mendoza AD, Escamilla M, et al
    Copy number variants in siblings of Mexican origin concordant for schizophrenia or bipolar disorder.
    Psychiatry Res. 2020;291:113018.
    PubMed     Abstract available

  262. JOHANSSON M, Hjarthag F, Helldin L
    Cognitive markers related to long-term remission status in Schizophrenia Spectrum Disorders.
    Psychiatry Res. 2020;289:113035.
    PubMed     Abstract available

  263. SJOLIE C, Meyn EK, Raudeberg R, Andreassen OA, et al
    Nonsocial cognitive underpinnings of theory of mind in schizophrenia.
    Psychiatry Res. 2020;289:113055.
    PubMed     Abstract available

  264. KITOKO GMB, Maurage P, Ma Miezi SM, Gillain B, et al
    Inter-individual variability of social perception and social knowledge impairments among patients with schizophrenia.
    Psychiatry Res. 2020;290:112951.
    PubMed     Abstract available

  265. HERMANS K, van der Steen Y, Kasanova Z, van Winkel R, et al
    Temporal dynamics of suspiciousness and hallucinations in clinical high risk and first episode psychosis.
    Psychiatry Res. 2020;290:113039.
    PubMed     Abstract available

  266. MARTIN DR, Gonzalez AJ, Perez CPL, Sesmero SA, et al
    New-onset psychosis in COVID-19 pandemic: a case series in Madrid.
    Psychiatry Res. 2020 May 13:113097. doi: 10.1016/j.psychres.2020.113097.

  267. RENTERO D, Juanes A, Losada CP, Alvarez S, et al
    New-onset psychosis in COVID-19 pandemic: a case series in Madrid.
    Psychiatry Res. 2020;290:113097.

  268. HUARCAYA-VICTORIA J, Herrera D, Castillo C
    Psychosis in a patient with anxiety related to COVID-19: A case report.
    Psychiatry Res. 2020;289:113052.

  269. HOSSAIN MM, Khan N, Sultana A, Ma P, et al
    Prevalence of comorbid psychiatric disorders among people with autism spectrum disorder: An umbrella review of systematic reviews and meta-analyses.
    Psychiatry Res. 2020;287:112922.
    PubMed     Abstract available

    April 2020
  270. MASAOKA Y, Velakoulis D, Brewer WJ, Cropley VL, et al
    Impaired olfactory ability associated with larger left hippocampus and rectus volumes at earliest stages of schizophrenia: A sign of neuroinflammation?
    Psychiatry Res. 2020;289:112909.
    PubMed     Abstract available

  271. KILIAN S, Asmal L, Phahladira L, Plessis SD, et al
    The association between childhood trauma and treatment outcomes in schizophrenia spectrum disorders.
    Psychiatry Res. 2020;289:113004.
    PubMed     Abstract available

  272. RANDERS L, Jepsen JRM, Fagerlund B, Nordholm D, et al
    Associations between facial affect recognition and neurocognition in subjects at ultra-high risk for psychosis: A case-control study.
    Psychiatry Res. 2020;290:112969.
    PubMed     Abstract available

  273. GAINSFORD K, Fitzgibbon B, Fitzgerald PB, Hoy KE, et al
    Transforming treatments for schizophrenia: Virtual reality, brain stimulation and social cognition.
    Psychiatry Res. 2020;288:112974.
    PubMed     Abstract available

  274. ZHU JL, Luo WW, Cheng X, Li Y, et al
    Vitamin D deficiency and Schizophrenia in Adults: A Systematic Review and Meta-analysis of Observational Studies.
    Psychiatry Res. 2020;288:112959.
    PubMed     Abstract available

  275. BAANDRUP L, Allerup P, Nielsen MO, Bak N, et al
    Rasch analysis of the PANSS negative subscale and exploration of negative symptom trajectories in first-episode schizophrenia - data from the OPTiMiSE trial.
    Psychiatry Res. 2020;289:112970.
    PubMed     Abstract available

  276. FISCHER M, Coogan AN, Faltraco F, Thome J, et al
    COVID-19 paranoia in a patient suffering from schizophrenic psychosis - a case report.
    Psychiatry Res. 2020;288:113001.

  277. VIDARSDOTTIR OG, Twamley EW, Roberts DL, Sigurdsson E, et al
    Integrative cognitive remediation for early psychosis: A 12-month follow-up.
    Psychiatry Res. 2020;288:112964.
    PubMed     Abstract available

  278. ADHAN I, Lizano P, Bannai D, Lutz O, et al
    Visual Cortical Alterations and their Association with Negative Symptoms in Antipsychotic-Naive First Episode Psychosis.
    Psychiatry Res. 2020;288:112957.
    PubMed     Abstract available

  279. CHEN S, Xia X, Deng C, Wu X, et al
    The correlation between metabolic syndrome and neurocognitive and social cognitive performance of patients with schizophrenia.
    Psychiatry Res. 2020;288:112941.
    PubMed     Abstract available

  280. TATAR O, Bastien G, Abdel-Baki A, Huynh C, et al
    A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis.
    Psychiatry Res. 2020;288:112940.
    PubMed     Abstract available

  281. DEAN B, Scarr E
    Muscarinic M1 and M4 receptors: Hypothesis driven drug development for schizophrenia.
    Psychiatry Res. 2020;288:112989.
    PubMed     Abstract available

  282. WANG KZ, Bani-Fatemi A, Adanty C, Harripaul R, et al
    Prediction of physical violence in schizophrenia with machine learning algorithms.
    Psychiatry Res. 2020;289:112960.
    PubMed     Abstract available

  283. BARADITS M, Bitter I, Czobor P
    Multivariate patterns of EEG microstate parameters and their role in the discrimination of patients with schizophrenia from healthy controls.
    Psychiatry Res. 2020;288:112938.
    PubMed     Abstract available

  284. ZANDIFAR A, Badrfam R
    COVID-19: Considering the prevalence of schizophrenia in the coming decades.
    Psychiatry Res. 2020;288:112982.

  285. DEL CACHO N, Vila-Badia R, Butjosa A, Cuadras D, et al
    Sexual dysfunction in drug- naive first episode nonaffective psychosis patients. Relationship with prolactin and psychotic symptoms. Gender differences.
    Psychiatry Res. 2020;289:112985.
    PubMed     Abstract available

    February 2020
  286. BAUER CCC, Okano K, Ghosh SS, Lee YJ, et al
    Real-time fMRI neurofeedback reduces auditory hallucinations and modulates resting state connectivity of involved brain regions: Part 2: Default mode network -preliminary evidence.
    Psychiatry Res. 2020;284:112770.
    PubMed     Abstract available

  287. DICKERSON F, Gennusa JV 3rd, Stallings C, Origoni A, et al
    Protein intake is associated with cognitive functioning in individuals with psychiatric disorders.
    Psychiatry Res. 2020;284:112700.
    PubMed     Abstract available

  288. ROSSELL SL, Labuschagne I, Castle DJ, Toh WL, et al
    Delusional themes in Body Dysmorphic Disorder (BDD): Comparisons with psychotic disorders and non-clinical Controls.
    Psychiatry Res. 2020;284:112694.
    PubMed     Abstract available

  289. DODELL-FEDER D, Shovestul B, Woodyatt J, Popov V, et al
    Social anhedonia, social networks, and psychotic-like experiences: A test of social deafferentation.
    Psychiatry Res. 2020;284:112682.
    PubMed     Abstract available

    September 2019
  290. ALLSOPP K, Read J, Corcoran R, Kinderman P, et al
    Heterogeneity in psychiatric diagnostic classification.
    Psychiatry Res. 2019;279:15-22.
    PubMed     Abstract available

    August 2019
  291. DE BOER JN, Vingerhoets C, Hirdes M, McAlonan GM, et al
    Efficacy and tolerability of riluzole in psychiatric disorders: A systematic review and preliminary meta-analysis.
    Psychiatry Res. 2019;278:294-302.
    PubMed     Abstract available

  292. KUO SS, Wojtalik JA, Mesholam-Gately RI, Keshavan MS, et al
    Establishing a standard emotion processing battery for treatment evaluation in adults with autism spectrum disorder: Evidence supporting the Mayer-Salovey-Caruso Emotion Intelligence Test (MSCEIT).
    Psychiatry Res. 2019;278:116-124.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.